glp 1 agonist for prediabetes GLP-1 Prevention: Using Drugs Like Zepbound for Pre-Diabetes or Metabolic Risk -What Does Research Say? GLP1 Receptor Agonists—Effects beyond Obesity
Description
Worsening of HF in the group of patients receiving dapagliflozin was 23% lower

Additionally, use caution when prescribing topiramate to pregnant women (increased risk of cleft palate) and to women on birth control pills (topiramate induces the metabolism of estrogen and can diminish the efficacy of the contraceptive)

In both -cells and intestinal L-cells, Gcg expression is controlled by certain homeodomain proteins [94,98,100] and by cAMP-activation of protein kinase A (PKA), as demonstrated in primary rat intestinal cultures [126], isolated pancreatic cell lines [127,128] and enteroendocrine GLUTag and STC-1 cell lines [129,130]

One benefit of GLP-1 receptor agonists is that they do not cause hypoglycemia when combined with metformin or thiazolidinediones, but the dose of concomitant sulphonylurea or insulin may have to be decreased to reduce the risk of hypoglycemic episodes
